Iron(III) Pincer Complexes as a Strategy for Anticancer Studies - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue European Journal of Inorganic Chemistry Année : 2017

Iron(III) Pincer Complexes as a Strategy for Anticancer Studies

Résumé

[Fe(NCN)2]PF6 (1·PF6) [NCHN = 1,3-di(pyridin-2-yl)benzene] was readily obtained by a transmetalation reaction between [Fe3(CO)12] and Hg(NCN)Cl followed by a metathesis reaction with KPF6. X-ray diffraction, electron paramagnetic resonance spectroscopy, and cyclic voltammetry studies confirmed the proposed structure. Cytotoxic assays in human colon cancer (HCT-15), lung cancer (SKLU), and gastric cancer (AGS, KATOIII) cells were performed, and the IC50 data obtained for all cell lines showed that 1·PF6 has a much higher activity than cisplatin.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-02365290 , version 1 (15-11-2019)

Identifiants

Citer

Aldo Estrada-Montaño, Alexander Ryabov, Alexandre Gries, Christian Gaiddon, Ronan Le Lagadec. Iron(III) Pincer Complexes as a Strategy for Anticancer Studies. European Journal of Inorganic Chemistry, 2017, 2017 (12), pp.1673-1678. ⟨10.1002/ejic.201601350⟩. ⟨inserm-02365290⟩
23 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More